EVO
Evotec SE
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · DE
$1.86
−2.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 135.50x
- P/S forward
- 0.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.85x
- Price / sales
- 0.79x
- Price / cash flow
- -4.78x
Enterprise value
- Enterprise value
- $673.0M
- EV / sales
- 0.80x
- EV / EBITDA
- -6.76x
- EV / EBIT
- -4.50x
- Market cap
- $661.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026